We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Biogen has filed suit against New York-based Creative Biolabs, claiming that the company has been copying its patented Alzheimer’s drug candidate aducanumab and selling imitation products to researchers online. Read More
Several drugmakers have committed to donating antimalaria treatments chloroquine and hydroxychloroquine after the Trump Administration showed interest in the drugs as potential COVID-19 treatments. Read More
Leaders of the House Energy and Commerce Committee asked FDA Commissioner Stephen Hahn how the agency intends to weigh priorities for the notification of shortages while protecting commercial information as the coronavirus continues to spread. Read More
Prescription drug prices increased by more than three times the rate of inflation between 2008 and 2017, according to a new analysis that accounts for rebates and discounts. Read More
The FDA reported the first U.S. drug shortage linked to the novel coronavirus outbreak — but did not name the drug. It is likely pindolol, a beta blocker for treatment of blood pressure manufactured by Mylan and Sun Pharma. Read More